CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines

New York, New York--(Newsfile Corp. - May 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alight, Inc. (NYSE: ALIT) between November 12, 2024 and February 18, 2026, both dates inclusive (the "Class Period"), of the important May 15, 2026 lead plaintiff deadline. SO WHAT: If you purchased Alight common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - May 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"), of the important May 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ImmunityBio securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

While the top- and bottom-line numbers for Hess Midstream Partners (HESM) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Although the revenue and EPS for ConocoPhillips (COP) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CSL Limited (CSLLY) Shareholder/Analyst Call Transcript

BSR Real Estate Investment Trust (HOM.UN:CA) Q1 2026 Earnings Call Transcript

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Phreesia between May 8, 2025 and March 30, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, May 14, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR) and reminds investors of the July 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

CHARLOTTE, N.C.--(BUSINESS WIRE)--The Board of Trustees of Barings Corporate Investors (NYSE: MCI) (the "Trust") met on May 14, 2026, and would like to report its preliminary financial results for the first quarter of 2026. Financial Highlights(1) Three Months Ended March 31, 2026 Three Months Ended December 31, 2025 Total Amount Per Share(5) Total Amount Per Share(4) Net investment income(2) $ 6,152,365 $0.30 $ 6,033,700 $ 0.29 Net realized gains / (losses)(3) $ (2,022,928) $(0.10) $ 199,709.

CHARLOTTE, N.C.--(BUSINESS WIRE)--The Board of Trustees of Barings Participation Investors (NYSE: MPV) (the "Trust") met on May 14, 2026, and would like to report its preliminary financial results for the first quarter of 2026. Financial Highlights(1) Three Months Ended March 31, 2026 Three Months Ended December 31, 2025 Total Amount Per Share(5) Total Amount Per Share(4) Net investment income(2) $ 2,912,137 $ 0.27 $ 2,866,556 $ 0.27 Net realized (losses) / gains(3) $(1,049,769) $(0.10) $ 1.

New York, New York--(Newsfile Corp. - May 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Vital Farms, Inc. (NASDAQ: VITL) between May 8, 2025 and February 26, 2026, both dates inclusive (the "Class Period"), of the important May 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Vital Farms securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
